Camber launches generic Pepcid
PISCATAWAY, N.J. –C amber Pharmaceuticals announces the addition of famotidine tablets to their current portfolio. Famotidine tablets are indicated in adult and pediatric patients 88lb and greater for the treatment of: active duodenal ulcer (DU) active gastric ulcer (GU) symptomatic nonerosive gastroesophageal reflux disease (GERD) Famotidine tablets are indicated in adults for the: treatment of pathological hypersecretory conditions (e.g.,